Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02846779 · ClinicalTrials.gov registry record · NA
Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6,000
- Enrollment target
NCT02846779: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02846779 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (328% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02846779, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,000 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.
Primary Outcome
Percentage of participants who were non-persistent if they did not refill insulin before a set threshold of time over the entire follow-up period
Interventions
- OTHER Low intensity
- OTHER Moderate intensity
- OTHER High intensity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-02-10 |
| Phase | NA |
What the finished NCT02846779 record still lists
NCT02846779 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (328% higher).
The record links to 0 conditions, and to 3 interventions - of which Low intensity is the first listed.
NCT02846779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02846779 about?
NCT02846779 is a clinical study titled "Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes". The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.
What is the current status of trial NCT02846779?
This trial is currently completed. It is a NA study. The enrollment target is 6,000 participants. The study started on 2016-07. Estimated completion is 2018-02-10.
What interventions are being tested in trial NCT02846779?
The interventions under investigation include: Low intensity (OTHER), Moderate intensity (OTHER), High intensity (OTHER).
Who is sponsoring clinical trial NCT02846779?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02846779's enrollment target sits among peer trials
6,000 22nd of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia